FPGS relapse-specific mutations in relapsed childhood acute lymphoblastic leukemia

Although the cure rate for childhood acute lymphoblastic leukemia (ALL) has exceeded 80% with contemporary therapy, relapsed ALL remains a leading cause of cancer-related death in children. Relapse-specific mutations can be identified by comprehensive genome sequencing and might have clinical signif...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Sung-Liang, Zhang, Hui, Ho, Bing-Ching, Yu, Chih-Hsiang, Chang, Chia-Ching, Hsu, Yin-Chen, Ni, Yu-Ling, Lin, Kai-Hsin, Jou, Shiann-Tarng, Lu, Meng-Yao, Chen, Shu-Huey, Wu, Kang-Hsi, Wang, Shih-Chung, Chang, Hsiu-Hao, Pui, Ching-Hon, Yang, Jun J., Zhang, Jinghui, Lin, Dong-Tsamn, Lin, Shu-Wha, Ma, Xiaotu, Yang, Yung-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374087/
https://www.ncbi.nlm.nih.gov/pubmed/32694622
http://dx.doi.org/10.1038/s41598-020-69059-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7374087/
https://www.ncbi.nlm.nih.gov/pubmed/32694622
http://dx.doi.org/10.1038/s41598-020-69059-y

Ejemplares similares